As a specific antagonist of the Wnt signaling pathway, DKK1 is potential in mediating dysfunctional glucolipid metabolism and IR, which is also a significant drug target in treating T2DM [23]. The gene discussed is DKK1; the disease is type 2 diabetes mellitus.